Human studies have mainly focused on safety, how the body handles the peptide, and metabolic markers such as IGF-1 and glucose levels, but have not shown strong evidence of weight loss
as an example, a concentration of 150 pmol/l on one day may be 120 pmol/l on another day
IV doses of 25-400 mcg/kg for safety studies Important: These are experimental doses used in animal studies and cannot be extrapolated to other species due to significant differences in metabolism, pharmacokinetics, receptor expression, peptide degradation rates, and tissue distribution patterns
They made everything so easy from purchasing/telehealth consultation to the how to video
[12] NAD+ Injection is generally reported to be well-tolerated, with a low incidence of serious adverse effects